ARL4C and colorectal carcinoma: Building on our earlier findings that ARL4C knockdown significantly suppresses CRC metastasis in combination with oxaliplatin, we further investigated whether β-Lapachone could substitute for ARL4C depletion to achieve similar anti-metastatic effects.